Megan D. Bailey serves as Executive at LABORATORY CORP OF AMERICA HOLDINGS, where they oversee executive responsibilities. Since joining the company, Megan D. Bailey has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 3, 2025 involved selling 179 shares valued at $46.2K.
Megan D. Bailey currently holds 3,594 shares of LABORATORY CORP OF AMERICA HOLDINGS (LH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Megan D. Bailey has been a net neutral trader of LH stock. They have purchased $0 and sold $0 worth of shares.
Megan D. Bailey's most recent insider trade was on Nov 3, 2025, when they sold 179 shares at $257.84 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 1, 2024 | LH | $14.9K | Payment | 69 | $216.35 | Discretionary |
| Apr 1, 2024 | LH | $0 | Option Exercise | 205 | $N/A | Discretionary |
| Feb 7, 2024 | LH | $0 | Option Exercise | 224 | $N/A | Discretionary |
| Feb 7, 2024 | LH | $5.8K | Payment | 26 | $223.71 | Discretionary |
| Feb 7, 2024 | LH | $19.5K | Payment | 87 | $223.71 | Discretionary |
| Feb 7, 2024 | LH | $0 | Option Exercise | 67 | $N/A | Discretionary |